← BioTransfer GEO Dataset Finder
GEO series

RNA-seq from atirmociclib resistant versus sensitive and vehicle treated HR+ HER2- ZR751 breast cancer xenografts .

GSE288580 Homo sapiens Expression profiling by high throughput sequencing 26 samples 2025/03/31 GPL30173
Summary
We investigated the mechanisms of acquired resistance to the CDK4 selective inhibitor atirmociclib in HR+ HER2- breast cancer in vivo, using the ZR751 xenograft model. Atirmociclib resistant tumors appeared after long-term (>50 day) treatment with atirmociclib. Tumor material was isolated from resistant (85-day treatment) as well as sensitive/vehicle treated (3-day) tumor bearing mice and subjected to RNA-seq analysis.
Download
NCBI GEO page ↗ Paper (PMID 40068598) ↗ {# Names what the click gives you. "Open in finder" meant nothing to a visitor who arrived from a search engine and has never seen the tool. #} Find more human RNA-seq datasets →
Similar datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.